Skip to main content

Harrow, Inc.

HROW
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001360214

In the last 90 days, Harrow, Inc. insiders filed 0 open-market purchases and 1 sale; 223 institutions reported holding it in 13F filings for Q2 2026, worth $912.6M in total; no superinvestor holds it.

Key figures

Insider buysOpen market, last 90 days
0
Insider sellsLast 90 days, $450.0K in total
1
13F holdersQ2 2026, +6 vs. previous quarter
223
13F valueReported value at the end of Q2 2026
$912.6M
Superinvestors holdingAt the end of Q2 2026
0

Price chart

Superinvestors holding HROW, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding HROW at the end of Q2 2026.

Latest insider trades

Open-market purchases and sales by Harrow, Inc. insiders from Form 4, newest first.

See all insider trades
Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 17, 2026 (view filing)5:47 PM ETAug 143 daysShojaei AmirCHIEF SCIENTIFIC OFFICERSSale−11.3K$40.00−$450.0K−100.0%0 after
May 19, 2026 (view filing)May 181 dayGraves Adrienne LDirectorPPurchase+1.00K$31.07+$31.1KNew position1.00K after
May 19, 2026 (view filing)May 181 daySilvernail Lauren PDirectorPPurchase+1.00K$31.00+$31.0KNew position1.00K after
May 15, 2026 (view filing)May 141 dayBaum Mark LCHIEF EXECUTIVE OFFICERPPurchase+10.0K$30.20+$302.0K+0.3%3.00M after
May 15, 2026 (view filing)May 141 dayBoll Andrew R.PRESIDENT AND CFOPPurchase+3.50K$29.90+$104.7K+0.4%814.7K after
Mar 5, 2026 (view filing)Mar 3-42 daysOpaleye Management Inc.10% OwnerSSaleCommon Stock, par value $0.001 per share−198.6K$39.51−$7.85M−77.0%59.4K after4 lots
Mar 3, 2026 (view filing)Feb 274 daysOpaleye Management Inc.10% OwnerSSaleCommon Stock, par value $0.001 per share−5.00K$54.18−$270.9K−7.1%65.0K after
Jan 8, 2026 (view filing)Jan 62 daysOpaleye Management Inc.10% OwnerSSaleCommon Stock, par value $0.001 per share−20.0K$53.35−$1.07M−22.2%70.0K after
Jun 11, 2025 (view filing)Jun 9-102 daysOpaleye Management Inc.10% OwnerSSaleCommon Stock, par value $0.001 per share−30.2K$30.58−$923.7K−25.1%90.0K after2 lots
Jun 5, 2025 (view filing)Jun 3-42 daysOpaleye Management Inc.10% OwnerSSaleCommon Stock, par value $0.001 per share−4.80K$30.03−$144.0K−3.8%120.2K after2 lots

Top 10 13F holders, Q2 2026

The largest institutional positions in Harrow, Inc. at the end of Q2 2026; share changes are against Q1 2026.

See all 223 holders
Institutions holding HROW in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
BlackRock, Inc.2,740,117$116.4M0.00%+187,358+7.3%Added
Opaleye Management Inc.2,400,000$101.9M9.23%−432,230−15.3%Reduced
Private Capital Management, LLC1,598,770$67.9M6.16%+36,770+2.4%Added
Vanguard Capital Management LLC1,417,212$60.2M0.00%+14,156+1.0%Added
Deep Track Capital, LP969,000$41.2M0.61%+969,000New
State Street Corp939,888$39.9M0.00%+84,841+9.9%Added
Geode Capital Management, LLC905,560$38.5M0.00%+53,526+6.3%Added
Bamco Inc809,350$34.4M0.05%+809,350New
Dimensional Fund Advisors LP667,036$28.3M0.01%+87,516+15.1%Added
Jupiter Topco LLC579,127$24.6M0.01%+579,127New